Insider Stock Trading History of O'neill Julie


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider O'neill Julie since year 2005. The trader's CIK number is 1630299. At the time of this reporting, O'neill Julie is the EVP. Global Operations of Alexion Pharmaceuticals Inc . (stock ticker symbol ALXN). See this page for all insider trading activities at Alexion Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider O'neill Julie since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-31 ALXN Alexion Pharmaceuticals Inc Sale 612 142.00 86,904
2017-09-05 ALXN Alexion Pharmaceuticals Inc Sale 3,763 146.06 549,642
2017-08-28 ALXN Alexion Pharmaceuticals Inc Sale 11,160 140.00 1,562,400
2017-03-02 ALXN Alexion Pharmaceuticals Inc Sale 651 133.80 87,103
2017-02-27 ALXN Alexion Pharmaceuticals Inc Sale 910 131.20 119,391
2017-02-28 ALXN Alexion Pharmaceuticals Inc Sale 664 131.70 87,448
2017-02-06 ALXN Alexion Pharmaceuticals Inc Sale 2,795 125.69 351,303
2016-09-02 ALXN Alexion Pharmaceuticals Inc Sale 650 126.29 82,088
2016-03-02 ALXN Alexion Pharmaceuticals Inc Sale 651 149.55 97,357
2016-02-29 ALXN Alexion Pharmaceuticals Inc Sale 663 138.91 92,097
2016-02-08 ALXN Alexion Pharmaceuticals Inc Sale 778 138.88 108,052
2016-02-05 ALXN Alexion Pharmaceuticals Inc Sale 2,080 143.48 298,442
2015-09-02 ALXN Alexion Pharmaceuticals Inc Sale 647 171.76 111,128
2015-02-27 ALXN Alexion Pharmaceuticals Inc Sale 5,100 .00 0
2015-03-02 ALXN Alexion Pharmaceuticals Inc Sale 6,565 180.34 1,183,932
2015-02-10 ALXN Alexion Pharmaceuticals Inc Sale 795 171.15 136,064

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'neill Julie (EVP. Global Operations of Alexion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.